-+ 0.00%
-+ 0.00%
-+ 0.00%

BioVie To Host Virtual Key Opinion Leader Event On May 7 To Discuss Phase 2 Trial Of Bezisterim To Treat Parkinson's Disease

Benzinga·04/27/2026 12:03:18
Listen to the news

BioVie Inc. (NASDAQ: BIVI) ("BioVie" or the "Company"), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases, today announced that it will host a virtual key opinion leader (KOL) event on Thursday, May 7, 2026 at 2:00 PM ET featuring Suzanne de la Monte, MD, MPH (Brown University Warren Alpert Medical School, Providence VA Medical Center), who will join company management to discuss how bezisterim's mechanism of action could potentially address the pathology and progression of neurodegenerative diseases, including Parkinson's disease.